Alpine Immune Sciences Inc (ALPN)
64.59
-0.01
(-0.02%)
USD |
NASDAQ |
May 06, 14:27
Alpine Immune Sciences Accounts Payable (Quarterly): 3.593M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.593M |
September 30, 2023 | 3.068M |
June 30, 2023 | 1.645M |
March 31, 2023 | 1.662M |
December 31, 2022 | 4.286M |
September 30, 2022 | 3.24M |
June 30, 2022 | 1.812M |
March 31, 2022 | 1.903M |
December 31, 2021 | 3.349M |
September 30, 2021 | 1.839M |
June 30, 2021 | 1.393M |
March 31, 2021 | 0.466M |
December 31, 2020 | 0.582M |
September 30, 2020 | 0.742M |
June 30, 2020 | 0.548M |
March 31, 2020 | 0.468M |
December 31, 2019 | 1.543M |
September 30, 2019 | 5.778M |
June 30, 2019 | 2.399M |
Date | Value |
---|---|
March 31, 2019 | 0.743M |
December 31, 2018 | 1.716M |
September 30, 2018 | 0.44M |
June 30, 2018 | 0.75M |
March 31, 2018 | 0.528M |
December 31, 2017 | 0.193M |
September 30, 2017 | 1.076M |
June 30, 2017 | 0.815M |
March 31, 2017 | 1.278M |
December 31, 2016 | 1.921M |
September 30, 2016 | 1.012M |
June 30, 2016 | 2.11M |
March 31, 2016 | 1.196M |
December 31, 2015 | 0.994M |
September 30, 2015 | 1.552M |
June 30, 2015 | 3.432M |
March 31, 2015 | 2.638M |
December 31, 2014 | 0.929M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.466M
Minimum
Mar 2021
5.778M
Maximum
Sep 2019
2.122M
Average
1.812M
Median
Jun 2022
Accounts Payable (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 364.90M |
Eliem Therapeutics Inc | 0.066M |
Regeneron Pharmaceuticals Inc | 671.30M |
Vera Therapeutics Inc | 11.12M |
Eyenovia Inc | 1.753M |